Performance evaluation of a line blot assay system for detection of anti-PM-Scl antibody in Japanese patients with systemic sclerosis.
Yasuhito HamaguchiMasataka KuwanaKazuhiko TakeharaPublished in: International journal of rheumatic diseases (2019)
Detection of anti-PM-Scl Ab assessed with a commercial LB assay requires extreme caution since it may yield false-positive data.
Keyphrases
- systemic sclerosis
- interstitial lung disease
- particulate matter
- air pollution
- high throughput
- loop mediated isothermal amplification
- label free
- real time pcr
- heavy metals
- polycyclic aromatic hydrocarbons
- electronic health record
- big data
- rheumatoid arthritis
- risk assessment
- idiopathic pulmonary fibrosis
- single cell